CrowdStrike reiterated its long-term ambition, which continues to anchor the model: reaching $10 billion in subscription ARR by fiscal 2031. Framed against today's run rate, this target assumes the ...
Amgen is undeterred by investors’ skepticism and is pushing forward aggressively with a broad phase 3 program that includes ...
Acadia Pharmaceuticals Inc. was downgraded after a drug setback, but strong sales and a robust pipeline offer investment ...
FEO VANCOUVER, BC, Sept. 25, 2025 /CNW/ – Oceanic Iron Ore Corp. (TSXV: FEO) (“Oceanic”, or the “Company”) is pleased to ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
Kingspan shares soared on Tuesday as the insulation manufacturer said it is considering floating its advanced building ...
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment Overall safety profile of BRIUMVI rema ...
Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key anti-cancer immune cytokines post-treatment ...
Akeso Inc. (9926.HK) is excited to announce that the Late-Breaking Abstract (LBA) from the registrational Phase ...
UEC Breakthrough Year Transitioning to Uranium Production in Wyoming, Burke Hollow Nearing Start-Up in Texas, and the Launch of U.S. Uranium Refining & Conversion Corp Creates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback